首页 | 本学科首页   官方微博 | 高级检索  
检索        

泮托拉唑、阿莫西林、呋喃唑酮三联疗法治疗幽门螺杆菌相关性十二指肠溃疡疗效观察
引用本文:臧国祥,熊国强,李淑莲.泮托拉唑、阿莫西林、呋喃唑酮三联疗法治疗幽门螺杆菌相关性十二指肠溃疡疗效观察[J].医学理论与实践,2001,14(6):493-495.
作者姓名:臧国祥  熊国强  李淑莲
作者单位:湖南省益阳市第二人民医院,413001
摘    要:目的:对比观察国产泮托拉唑与奥美拉唑及雷尼替丁+铋剂对十二指肠溃疡(DU)的治愈率及幽门螺杆菌(Hp)的根除率。方法:104例Hp相关性DU门诊患者,按2:1:1随机分成A组52例、B组28例和C组24例。A组:泮托拉唑40mg qd+阿莫西林1000mg bid+呋喃唑酮100mg bid×7d,继服泮托拉唑40mg qd×21d;B组:奥美拉唑20mg bid+阿莫西林1000mg bid+呋喃唑酮100mg bid×7d,改奥美拉唑20mg qd×21d;C组:雷尼替丁150mgbid+丽珠得乐100mg qid+阿莫西林500mg tid+甲硝唑400mg tid×14d,继服雷尼替丁150mg bid×28d。结果:ABC三组溃疡治愈率分别为94.2%、92.9%和62.5%;Hp根除率分别为94.2%、92.9%和66.7%。结论:由泮托拉唑组成的低剂量短程新三联疗法,对DU的疗效和Hp清除率与奥美拉唑组比较无明显差异(P>0.05),而明显优于雷尼替丁、铋剂四联疗法(P<0.01),成本效益比仅为B组的1/2~2/3,药物副反应不足C组的1/3。方案A是一种新的高效、经济、安全实用的Hp根除方案。

关 键 词:泮托拉唑  幽门螺杆菌  十二指肠溃疡
修稿时间:2001年3月20日

Triple Therapy with Pantoprazole, Amoxicillin and Furazolidone for Treatment of Duodenal Ulcer Associated with Helicobacter Pylori
Zang Guoxiang,Xiong Guoqiang,Li Shulian.Triple Therapy with Pantoprazole, Amoxicillin and Furazolidone for Treatment of Duodenal Ulcer Associated with Helicobacter Pylori[J].The Journal of Medical Theory and Practice,2001,14(6):493-495.
Authors:Zang Guoxiang  Xiong Guoqiang  Li Shulian
Abstract:Objective: To explore the optimal regimens for eradication of Helicobacter pylori (HP) and the treatment of duodenal ulcer (DU). Methods:The 104 patients with DU assoiated with Hp were randomly divided into three groups. Group A (n = 52) were treated with triple therapy of pantoprazole 40mg qd amoxicillin(amo) 1000mg bid farazolidone (Fur) 100mg bid for 1 week, and were treated with Pan 40mg/day for 3 weeks after anti - Hp therapy;Group B( n =28), were treated with triple therapy of omeprazole (ome )20mg bid Amo 1000mg bid Fur 100mg bid for 1 week, and were treated with Ome 20mg/day for 3 weeks after anti-HP therapy. Group C ( n = 24) were treated with fourfold therapy of renitidine (Ren) 150mg bid Tripotassium Dicifobismuphate (Tri) 100mg qid Amo 500mg tid Miediling (Mie) 400mg lid for 2 weeks,and were treated with Ren 150mg bid for 4 week after anti - HP therapy, after month of anti-HP therapy the endoscopy and examination of HP were repeated. Results: The healing rates of active DU in group A,B,C were 94.2% ,92.9% ,62.5% .respectively.The eradication rates of HP in group A.B.C were 94.2% ,92. 9% ,66.7% , and the occurrence of side effects in group A,B,C were 7.7% ,7.1 % and 29.2% .respectively. The group A is quite different from the group C in the healing rates of ulcer, the eradication rates of HP and the occurrence of side effects ( P< 0. 01) .while the group A has no marked difference with the group B (P >0.05). Conclusion :The regimens A.B are highly effective in the eradicetion of HP infection and the healing of active DU. But the regimen A is optimal and practical because of Little side effect, lower cost and no resistance of HP strains.
Keywords:Pantoprazole  Helicobacter pylori  Duodenal ulcer
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号